Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
Isoptin 2.5mg/ml Solution for Injection or Infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection or infusion. A clear, colourless, sterile, aqueous solution. |
1ml of solution contains 2.5mg of Verapamil Hydrochloride.
Each ampoule contains 2ml of solution containing 5mg of verapamil hydrochloride.
Excipients: contains 17 mg of sodium under the sodium chloride form.
For a full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Verapamil |
Verapamil inhibits the transmembrane influx of calcium ions into the heart and vascular smooth muscle cell. The myocardial oxygen demand is lowered directly as a result of the effect on the energy consuming metabolic processes of the myocardial cell and indirectly due to a reduction of the afterload. Due to its effect on coronary vascular smooth muscle, verapamil enhances myocardial blood flow, even in post‐stenotic areas, and relieves coronary spasms. These properties contribute to the anti‐ischaemic and antianginal efficacy of verapamil in all types of coronary artery disease. |
| List of Excipients |
|---|
|
Sodium chloride |
2ml ampoules of Ph. Eur. type I glass.
Each pack contains: 5 × 2ml ampoules.
Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
PA2010/003/004
Date of first authorisation: 01 April 1980
Date of last renewal: 01 April 2010
| Drug | Countries | |
|---|---|---|
| ISOPTIN | Austria, Australia, Canada, Cyprus, Germany, Estonia, Finland, Hong Kong, Croatia, Ireland, Italy, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
